Interim financial report for the period 1 January 2009 to 30 September 2009
29 October 2009
Novo Nordisk increased operating profit by 30% in the first nine months of 2009. Sales increased by 15% in Danish kroner and by 11% in local currencies. Sales of modern insulins increased by 28% (24% in local currencies). Sales of NovoSeven®increased by 15% (11% in local currencies). Sales of Norditropin® increased by 15% (9% in local currencies).
RSS Feed
The latest Novo Nordisk news are now available through Really Simple Syndication - RSS.
